CRO Concept

1,387.66

+39.532.93%

Number of Gainers:2

Number of Losers:- -

Number of Flat:1

PE:- -

High:1,429.99

Open:1,346.88

Low:1,336.46

Close:1,348.13

Loading ...

Overview News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":1387.661,"timestamp":1751399999999,"preClose":1348.1335,"halted":0,"volume":2506833,"delay":0,"changeRate":0.02932,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":39.527466,"latestTime":"07-01 16:00:00 EDT","open":1346.8755,"high":1429.9854,"low":1336.4586,"amount":401461012.847211,"amplitude":0.069375,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751443200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.773731,"peRate":26.332668,"turnoverRate":0.011769,"increases":2,"decrements":0,"flats":0,"marketCap":35714996224,"floatMarketCap":34239346176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":1429.9854,"amplitude":0.069375,"preClose":1348.1335,"low":1336.4586,"pbRate":"3.773731","latestPrice":1387.661,"volume":2506833,"delay":0,"open":1346.8755,"prevYearClose":1673.3123,"prevWeekClose":1344.2366,"prevMonthClose":1348.1335,"prevQuarterClose":1348.1335,"fiveDayClose":1348.922,"twentyDayClose":1192.4003,"sixtyDayClose":1395.9784,"secType":"PLATE","market":"US","turnoverRate":0.011769,"peRate":26.332668,"marketCap":35714996224,"floatMarketCap":34239346176,"timestamp":1751399999999,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":2,"down":0,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548800351","title":"IQVIA Holdings Inc. to Announce Second-Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2548800351","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548800351?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:00","pubTimestamp":1751367622,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IQVIA Holdings Inc. published the original content used to generate this news brief via Business Wire  on July 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL9ZrWLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","LU0130518102.USD","LU0477156797.USD","LU0130102774.USD","LU1989764748.USD","LU0130103400.USD","BK4530","BK4121","LU1791710400.SGD","LU0528227936.USD","IQV","BK4588","LU0882574055.USD","LU0130517989.USD","LU1201861165.SGD","LU1261432733.SGD","LU0980610538.SGD","LU0648001328.SGD","LU1989764664.SGD","LU0477156953.USD","LU1791710582.SGD","LU0198837287.USD","BK4585","LU0648000940.SGD"],"gpt_icon":0},{"id":"2548012486","title":"Unicycive Receives FDA CRL for New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2548012486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548012486?lang=en_us&edition=fundamental","pubTime":"2025-07-01 02:58","pubTimestamp":1751309908,"startTime":"0","endTime":"0","summary":"An update from Unicycive Therapeutics ( ($UNCY) ) is now available. On June 30, 2025, Unicycive Therapeutics announced that the FDA issued a Comple...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/unicycive-receives-fda-crl-for-new-drug-application?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/unicycive-receives-fda-crl-for-new-drug-application?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0390134368.USD","BK4530","BK4139","CRL","UNCY","LU0757428866.USD","BK4121","LU1815336091.USD","BK4588","BK4539"],"gpt_icon":0},{"id":"2547096513","title":"Unicycive receives CRL for oxylanthanum carbonate NDA for hyperphosphatemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2547096513","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547096513?lang=en_us&edition=fundamental","pubTime":"2025-06-30 19:24","pubTimestamp":1751282677,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) announced that the U.S. Food and Drug Administration has issued a CRL for its New Drug Application for OLC to treat h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-receives-crl-for-oxylanthanum-carbonate-nda-for-hyperphosphatemia-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-receives-crl-for-oxylanthanum-carbonate-nda-for-hyperphosphatemia-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","CRL","BK4588","LU1815336091.USD","BK4121","UNCY","LU0757428866.USD","LU0390134368.USD","BK4530","BK4139"],"gpt_icon":0},{"id":"2546928562","title":"IQVIA Holdings (IQV) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2546928562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546928562?lang=en_us&edition=fundamental","pubTime":"2025-06-25 16:26","pubTimestamp":1750839985,"startTime":"0","endTime":"0","summary":"In a report released today, Luke Sergott from Barclays maintained a Hold rating on IQVIA Holdings (IQV – Research Report), with a price target of $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/iqvia-holdings-iqv-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/iqvia-holdings-iqv-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0130102774.USD","LU0477156797.USD","LU0130517989.USD","LU1791710582.SGD","LU0130518102.USD","LU1989764664.SGD","LU0648000940.SGD","BK4588","IQV","LU0477156953.USD","LU1791710400.SGD","LU0198837287.USD","LU1261432733.SGD","LU1989764748.USD","LU1201861249.SGD","LU0980610538.SGD","LU0648001328.SGD","BK4530","BK4121","LU0130103400.USD","LU1201861165.SGD","BK4585","LU0882574055.USD","LU0528227936.USD"],"gpt_icon":0},{"id":"2546294719","title":"Charles River Labs (CRL) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2546294719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546294719?lang=en_us&edition=fundamental","pubTime":"2025-06-25 16:26","pubTimestamp":1750839971,"startTime":"0","endTime":"0","summary":"In a report released today, Luke Sergott from Barclays maintained a Hold rating on Charles River Labs (CRL – Research Report), with a price target ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/charles-river-labs-crl-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/charles-river-labs-crl-gets-a-hold-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0390134368.USD","BK4121","LU0757428866.USD","BK4530","BK4588","LU1815336091.USD","BK4585","CRL"],"gpt_icon":0},{"id":"2546253318","title":"Stifel calls report of Makary pushing for KalVista CRL ‘highly surprising’","url":"https://stock-news.laohu8.com/highlight/detail?id=2546253318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546253318?lang=en_us&edition=fundamental","pubTime":"2025-06-25 04:16","pubTimestamp":1750796161,"startTime":"0","endTime":"0","summary":"After Endpoints News reported that FDA Commissioner Dr. Marty Makary requested drug reviewers to issue a Complete Response Letter for sebetralstat,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/stifel-calls-report-of-makary-pushing-for-kalvista-crl-highly-surprising-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/stifel-calls-report-of-makary-pushing-for-kalvista-crl-highly-surprising-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4588","LU1815336091.USD","BK4127","LU0757428866.USD","BK4585","LU0390134368.USD","CRL","BK4530","SF"],"gpt_icon":0},{"id":"2545779201","title":"JonesResearch says CRL would not be end for Capricor’s deramiocel","url":"https://stock-news.laohu8.com/highlight/detail?id=2545779201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545779201?lang=en_us&edition=fundamental","pubTime":"2025-06-21 03:05","pubTimestamp":1750446325,"startTime":"0","endTime":"0","summary":"JonesResearch analyst Catherine Novack says multiple sources have reported that Nicole Verdun, director of Center for Biologics Evaluation and Rese...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jonesresearch-says-crl-would-not-be-end-for-capricors-deramiocel-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jonesresearch-says-crl-would-not-be-end-for-capricors-deramiocel-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4588","LU1815336091.USD","LU0757428866.USD","BK4585","LU0390134368.USD","CRL","BK4530"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}